Cargando…
The COVID-19 pandemic: an increased risk of rheumatoid arthritis
COVID-19 is a respiratory infection similar to viral pneumonia and is caused by SARS-CoV-2. Chloroquine and hydroxychloroquine make up the major part of the treatment regimen for the management of COVID-19 infections, which are also commonly used in treatment of patients with malaria as well as auto...
Autores principales: | Tripathy, Archana, Swain, Nitish, Gupta, Bhawna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221023/ https://www.ncbi.nlm.nih.gov/pubmed/34181704 http://dx.doi.org/10.2217/fvl-2020-0393 |
Ejemplares similares
-
Direct recognition of LPS drive TLR4 expressing CD8(+) T cell activation in patients with rheumatoid arthritis
por: Tripathy, Archana, et al.
Publicado: (2017) -
Rheumatoid Arthritis in the Era of COVID-19 Pandemic
por: Abbas, Ahmed M., et al.
Publicado: (2020) -
Managing Rheumatoid Arthritis with Dietary Interventions
por: Khanna, Shweta, et al.
Publicado: (2017) -
Rheumatoid Arthritis Linked to an Increased Risk of COPD
Publicado: (2017) -
Rheumatoid arthritis increases the risk of pleural empyema
por: Liao, Kuang-Ming, et al.
Publicado: (2020)